He highlighted Flyrcado -- a positron emission tomography myocardial perfusion imaging (PET MPI) agent approved in September 2024 -- which GE HealthCare has projected as a $500M opportunity by 2028.

Introduction to Digital Health and WellnessThe digital health and wellness industry is experiencing significant growth as healthcare increasingly incorporates technology to improve the quality, ...

All participants underwent head MRI scans (3.0T, GE Discovery 750 W, USA), including diffusion ... CBF radiomics features provide distinct information on alterations in cerebral blood perfusion status ...

Getinge will gradually phase out its surgical perfusion business, to focus on more profitable growth areas such as ECLS and ...

Getinge said Tuesday it will phase out its surgical perfusion business and reallocate resources to higher-growth areas such as extracorporeal membrane oxygenation (ECMO) and transplant care.

LivaNova (LIVN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Matson from Needham maintained a Buy rating on the stock and has a ...

Yet, perfusion MRI approaches are not easy to implement for whole-brain research in mice due to their small size. This non-invasive, repeatable, simple hypoxia BOLD-MRI method is capable of ...

GE Healthcare Technologies (GEHC) is investing $138 million to expand a manufacturing site in Ireland to meet growing demand ...